PlainRecalls
FDA Drug Moderate Class II Terminated

Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-0659-07, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, Repackaged NDC 70518-2404-00.

Reported: January 18, 2023 Initiated: December 20, 2022 #D-0098-2023

Product Description

Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-0659-07, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, Repackaged NDC 70518-2404-00.

Reason for Recall

Failed Impurities/Degradation specifications

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
132 Cards of 30 = 3960 Tablets
Distribution
Product was distributed to one account in PA.
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-0659-07, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, Repackaged NDC 70518-2404-00.. Recalled by RemedyRepack Inc.. Units affected: 132 Cards of 30 = 3960 Tablets.
Why was this product recalled?
Failed Impurities/Degradation specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on January 18, 2023. Severity: Moderate. Recall number: D-0098-2023.